Mercury Bio
- 31/08/2023
- Seed
- $2,000,000
We want to shift the paradigm in drug delivery systems.
Mercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific delivery—targeting only the cells that need therapy and working with the body to bypass immune reactions.
Not only will our technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process.
By advancing drug efficacy, lowering costs, reducing side effects, and shortening time to market, we aim to unlock the potential of new therapies and help make the world’s most advanced medicines more accessible to everyone.
- Industry Biotechnology Research
- Website https://www.mercurybio.com/
- LinkedIn https://www.linkedin.com/company/mercury-bio/about/
Related People
Bruce McCormickFounder
Problem finder, solution creator, inventor of the ridiculous to the revelatory. Creating dozens of US and foreign patents I have learned that there are many ways of seeing the world. There are process thinkers, outside the box thinkers and there are also inspired thinkers. I believe the most critical factor in problem solving is problem identification. Proper and deep identification of the issue at hand is essential to efficient and elegant solutions. Questioning the question is the pathway to successful problem solving. Blind adherence to stated problems is not likely to produce innovation.
My career began developing housing for the underserved in NY urban areas. In the early 90’s the need to develop ideas overcame my need to build housing. My first invention led to a project with NASA and their EVA department. This included an Antarctica mission in which I was communicating with scientists daily via this new thing called the internet, which I accessed with a dial up connection relying on once a day satellite passes. This led to the approval of an FDA cleared medical device for cardiac and pulmonary indications.
Further inventions included real time motion analysis equipment, garment measuring equipment and system, insulated insoles, a solar ice making system, cryogenic phase change material and most recently a range of equipment and software designed and used currently used for vaccine delivery in the emerging cell and gene therapy sciences. Some of these products have made the cover of Popular Science magazine, been exhibited in the US Patent museum and have been written about in many publications including the NY times.
Developing a solution for the local transportation of the Ebola vaccine trials was an accomplishment I am very proud of in addition to the work done at SAVSU technologies to help advance the growth of the amazing cell and gene therapy sciences.
CEO of Mercury Bio, working with an amazing group of scientists building a new advanced drug delivery system utilizing yEVs. Recent engagements include serving as Sr VP of Cold Chain Technologies at BioLife Solutions as well as President and CTO of SAVSU Technologies. When not working I try to get some time sailing and skiing.